Cargando…
Potential therapeutic targets and small molecular drugs for pediatric B-precursor acute lymphoblastic leukemia treatment based on microarray data
The current study investigated the molecular mechanisms underlying pediatric acute lymphoblastic leukemia (ALL) and screened for small molecular drugs as supplementary drugs to aid current therapy. Gene expression data of Gene Expression Omnibus (GEO) DataSet GSE42221, which consists of 7 primary hu...
Autores principales: | Kong, Limei, Zhang, Xiaowei, Li, Chao, Zhou, Liping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5529867/ https://www.ncbi.nlm.nih.gov/pubmed/28789378 http://dx.doi.org/10.3892/ol.2017.6343 |
Ejemplares similares
-
SYK as a New Therapeutic Target in B-Cell Precursor Acute Lymphoblastic Leukemia
por: Uckun, Fatih M., et al.
Publicado: (2014) -
Therapeutic Targeting of MERTK and BCL-2 in T-Cell and Early T-Precursor Acute Lymphoblastic Leukemia
por: Summers, Ryan J., et al.
Publicado: (2022) -
Chromatin accessibility landscape of pediatric T‐lymphoblastic leukemia and human T‐cell precursors
por: Erarslan‐Uysal, Büşra, et al.
Publicado: (2020) -
The epigenome in pediatric acute lymphoblastic leukemia: drug resistance and therapeutic opportunities
por: Meyer, Lauren K., et al.
Publicado: (2019) -
Therapeutic targeting of mutant p53 in pediatric acute lymphoblastic leukemia
por: Demir, Salih, et al.
Publicado: (2020)